Global Picture Archiving and Communication System Market Report

The “Global Picture Archiving and Communication System Market 2022-2026” report has been added to ResearchAndMarkets.com‘s offering.

The picture archiving and communication system market is poised to grow by $1.34 bn during 2022-2026, accelerating at a CAGR of 5.89% during the forecast period. The report on the picture archiving and communication system market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by government initiatives encouraging IT adoption in healthcare, increasing adoption of PACS by small hospitals and imaging centers, and increasing demand for mobile PACS.

The picture archiving and communication system market analysis includes the product and application segments and geographic landscape.

The picture archiving and communication system market is segmented as below:

By Product

  • Mid-end PACS
  • Enterprise PACS
  • Mini PACS

By Application

  • Radiology PACS
  • Cardiology PACS
  • Pathology PACS

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the emergence of cloud-based PACS as one of the prime reasons driving the picture archiving and communication system market growth during the next few years. Also, increasing healthcare expenditure and increasing providers for patient-centered radiology solutions will lead to sizable demand in the market.

The report on the picture archiving and communication system market covers the following areas:

  • Picture archiving and communication system market sizing
  • Picture archiving and communication system market forecast
  • Picture archiving and communication system market industry analysis

Key Topics Covered:

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Five Forces Analysis

5 Market Segmentation by Product

6 Market Segmentation by Application

7 Customer Landscape

8 Geographic Landscape

9 Drivers, Challenges, and Trends

10 Vendor Landscape

11 Vendor Analysis

12 Appendix

Companies Mentioned

  • 314e Corp.
  • Agfa Gevaert NV
  • Apollo Enterprise Imaging Corp.
  • Ashva Technologies Pvt. Ltd.
  • Carestream Health Inc.
  • Cerner Corp.
  • Dell Inc.
  • Esaote Spa
  • FUJIFILM Holdings Corp.
  • General Electric Co
  • Intelerad Medical Systems Inc.
  • International Business Machines Corp.
  • Koninklijke Philips NV
  • Laitek Inc.
  • Lexmark International Inc.
  • McKesson Corp.
  • Novarad Corp.
  • PaxeraHealth
  • Sectra AB
  • Siemens AG

For more information about this report visit here.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”